Is Weak Acid Beneficial for Addressing Checkpoint Inhibitor–Triggered Cancer Hyper Progression in Anti-PD1/PD-L1 Immunotherapies?

Numerous cases of checkpoint inhibitor–triggered cancer hyperprogression have been documented. A previous hypothesis attributes cancer onset to the local buildup of hydrogen chloride, jointly mediated by hydrogen bond donors and acceptors and basic amino acids. The anti-PD1/PD-L1 immunotherapies may...

Descripción completa

Detalles Bibliográficos
Autores principales: Wan, Yulin, An, Shanshan, Zhou, Yanchao, Zhang, Jiaming, Zhang, Ying, Gan, Tao, Liu, Qiuyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Commentary & View
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7513399/
https://www.ncbi.nlm.nih.gov/pubmed/32959668
http://dx.doi.org/10.1177/1073274820944290

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7513399/
https://www.ncbi.nlm.nih.gov/pubmed/32959668
http://dx.doi.org/10.1177/1073274820944290

Ejemplares similares